本页面由Tiger Trade Technology Pte. Ltd.提供服务

MoonLake Immunotherapeutics

15.37
-0.3900-2.47%
盘后15.370.00000.00%19:30 EDT
成交量:113.81万
成交额:1,752.55万
市值:13.08亿
市盈率:-4.03
高:15.69
开:15.68
低:15.23
收:15.76
52周最高:62.75
52周最低:5.95
股本:8,510.67万
流通股本:5,546.84万
量比:0.92
换手率:2.05%
股息:- -
股息率:- -
每股收益(TTM):-3.8139
每股收益(LYR):-3.5300
净资产收益率:-67.47%
总资产收益率:-32.44%
市净率:3.05
市盈率(LYR):-4.35

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/15

重要事件披露

Form 8-K - Current report
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities